Skip to main content

Noteless

Category: AI in Healthcare

AI-powered clinical note-taking platform that automates medical documentation for healthcare professionals Noteless was founded in 2023. The company is led by William Vossgård. Based in Oslo, Norway. Team size: 51-100. Total funding raised: €3.5 million. Latest round: Seed. Key investors include Redstone, Futurum Ventures, Farvatn Venture.

Founded
2023
Headquarters
Oslo, Norway
Team size
51-100
Total funding
€3.5 million

Value proposition

Saves doctors up to 2 hours daily on administrative tasks by automatically generating clinical notes from patient consultations

Products and solutions

AI-driven ambient clinical documentation / medical scribe, Customizable medical templates, EHR integrations including Noteless Chrome extension for browser-based EHRs, Data analytics for practice management, Multilingual support (English, German, Spanish, French, Dutch, Norwegian and more), Support for GPs, specialists, physiotherapists, psychologists

Unique value

Specializes in reducing physician burnout through AI automation of clinical documentation; company reports 1 in 4 GPs in Norway and Denmark use Noteless daily, over 5 million patient consultations processed, ISO-certified and CE-marked medical device, largest ambient scribe in the Nordics

Target customer

General practitioners, specialists, physiotherapists, psychologists, and other healthcare providers primarily in Norway, Denmark, Netherlands, UK, and Germany, with expansion into Spain, Italy, and France

Industries served

Healthcare, Medical Documentation, HealthTech, Artificial Intelligence

Technology advantage

Advanced natural language processing (NLP) and speech recognition tailored for medical workflows, combined with a user-centric design validated by medical professionals. Processes 100,000+ consultations weekly with seamless EHR integration

How they differentiate

Doctor-built ambient AI medical scribe focused on reducing administrative burden and burnout; CE-marked medical device, ISO-certified; deep Nordic penetration (company reports ~1 in 4 GPs in Norway and Denmark) with European expansion; browser Chrome extension and local EHR integrations (e.g. HealthConnected NL)

Main competitors

Abridge, Nuance / Microsoft DAX, Nabla, Heidi Health

Key partnerships

Redstone (lead investor), Futurum Ventures, Farvatn Venture, HealthConnected (HIS) — AI documentation integration for Dutch primary care (Apr 2026), AI Coalitie 4 Nederland / AIC4NL (member since Mar 2026), Integration partnerships with EHR providers in Nordic/European markets, Norwegian Research Council (SkatteFUNN scheme), Helse Møre og Romsdal HF (pilot partner)

Notable customers

1 in 4 general practitioners in Norway and Denmark (company claim), ~3,000 clinicians across NO/DK/UK/DE/NL (as of Nov 2025 seed), Helse Møre og Romsdal HF, HealthConnected (HIS) users in Dutch primary care, Thousands of clinicians across hospitals, GP practices, psychiatry, and municipalities

Major milestones

€3.5M seed funding Nov 2025 (Redstone-led), Moved out of Aleap incubator (April 2025), Processed over 5 million consultations (LinkedIn company About, 2026), Grew to ~53 employees (LinkedIn, 2026), Joined AI Coalitie 4 Nederland / AIC4NL (March 2026), HealthConnected (HIS) integration partnership for Dutch primary care (April 2026), Launched Noteless Chrome extension for browser-based EHRs, German Hausärztetag Baden-Württemberg audience prize

Growth metrics

360%+ paying customer growth reported at Nov 2025 seed; ~53 employees (LinkedIn, 2026); over 5 million consultations processed; 100,000+ consultations weekly (as of seed); ~3,000 clinicians across NO/DK/UK/DE/NL at seed; expanding further into Spain, Italy, France, Netherlands

Market positioning

Positioned as a specialized solution for administrative burden reduction in clinical workflows, targeting primary care physicians in the Nordics and expanding to UK and Germany. Competes with broader healthcare AI platforms by emphasizing doctor-centric design and rapid adoption

Geographic focus

Primary: Norway, Denmark, Netherlands, UK, Germany; expanding into Spain, Italy, and France; Nordic leadership in ambient clinical scribes

Patents and IP

No publicly disclosed patents identified as of December 2025

About William Vossgård

Co-founder and CEO of Noteless since October 2023. Previously worked as Co-Founder at VISOAL. Under his leadership, Noteless has achieved remarkable growth with 360% increase in paying customers since start of 2024, and secured €3.5 million in seed funding. Recognized speaker at LSX Nordic Congress.

More AI in Healthcare companies

Official website: